Public Profile

GE Healthcare Bio-Sciences AB

GE Healthcare Bio-Sciences AB, a prominent player in the life sciences sector, is headquartered in Sweden (SE) and operates extensively across Europe and North America. Founded in the early 2000s, the company has established itself as a leader in bioprocessing and laboratory solutions, focusing on innovative technologies that enhance the efficiency of drug development and production. Specialising in chromatography, filtration, and cell culture products, GE Healthcare Bio-Sciences offers unique solutions that cater to the needs of biopharmaceutical manufacturers and researchers. Their commitment to quality and innovation has positioned them as a trusted partner in the industry, contributing to significant advancements in healthcare. With a strong market presence, the company continues to achieve notable milestones, reinforcing its reputation as a key contributor to the global life sciences landscape.

DitchCarbon Score

How does GE Healthcare Bio-Sciences AB's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

52

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

GE Healthcare Bio-Sciences AB's score of 52 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.

87%

Let us know if this data was useful to you

GE Healthcare Bio-Sciences AB's reported carbon emissions

GE Healthcare Bio-Sciences AB, headquartered in Sweden (SE), currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or climate commitments. Without specific emissions figures or documented initiatives, it is challenging to assess their environmental impact or progress in addressing climate change. The company may be engaged in broader industry efforts to reduce carbon footprints, but specific details on their commitments or achievements are not provided.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. GE Healthcare Bio-Sciences AB's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for GE Healthcare Bio-Sciences AB is in SE, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

GE Healthcare Bio-Sciences AB is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers